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Background
Monoclonal antibody based vaccines are effective and
highly specific in disease targeting. Presently, most of the
existing broadly neutralizing antibodies are generated
against non subtype c viruses. HIV-1 subtype c accounts
for more than 90% of infection in India. The disease pro-
gression in children is faster than adults.
Methods
Nine ART drug naïve HIV-1 subtype c infected children
were recruited. PBMCs were isolated from all the sub-
jects and pooled. RNA was isolated and cDNA was
synthesized followed by amplification of VH and VL
chain genes and scFv construction. A human recombi-
nant scFv phage display library of 108 clones was con-
structed. Diversity of the phage library was checked by
DNA sequencing and biopanned with RSC3 core anti-
gen. 60 random clones were screened by phage ELISA.
Expression of the scFvs was assessed by SDS-PAGE and
Western blotting.
Results
The diversity of the phage library was more than 90%.
Eight scFv monoclonals showed positive binding in phage
ELISA and two best binders were further characterized.
Both scFvs didn’t show any reactivity with unrelated anti-
gens. DNA fingerprinting analysis showed both scFvs were
distinct. A 32kDa band was obtained in SDS-PAGE and
Western blot. Both scFvs showed cross neutralizing activ-
ity against a standard panel of pseudoviruses.
Conclusion
Here, we have for the first time generated a human recom-
binant scFv phage display library containing neutralizing
clones from HIV-1 infected children. Further characteriza-
tion of these scFvs generated against CD4 binding site for
their epitope mapping would be helpful in the develop-
ment of an effective HIV-1 vaccine.
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